Inventor · disambiguated record
Jeffrey Kurz
Also filed as: KURZ JEFFREY · KURZ JEFFREY C
13 granted patents·8 pending applications·188 citations·filing 2002–2022
92Inventor score
Top patents by PatentIndex Score
21 records- 0193US7538211B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX CORP·Filed 2005·Granted May 26, 2009·33 cites·7 claims
- 0292US7803931B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX CORP·Filed 2005·Granted Sep 28, 2010·19 cites·5 claims
- 0392US7579456B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX CORP·Filed 2006·Granted Aug 25, 2009·24 cites·6 claims
- 0490US7125660B2Nucleic acid sensor molecules and methods of using sameARCHEMIX CORP·Filed 2002·Granted Oct 24, 2006·77 cites·54 claims
- 0588US8236773B2Aptamer therapeutics useful in the treatment of complement-related disordersBENEDICT CLAUDE·Filed 2006·Granted Aug 7, 2012·9 cites·10 claims
- 0687US10947544B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2019·Granted Mar 16, 2021·1 cites·5 claims
- 0786US8436164B2Aptamer therapeutics useful in the treatment of complement-related disordersBENEDICT CLAUDE·Filed 2012·Granted May 7, 2013·6 cites·15 claims
- 0884US9617546B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2014·Granted Apr 11, 2017·4 cites·5 claims
- 0983US8598327B2Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeuticsSCHAUB ROBERT·Filed 2011·Granted Dec 3, 2013·10 cites·19 claims
- 1077US11913000B2Aptamer therapeutics useful in the treatment of complement-related disordersIVERIC BIO INC·Filed 2021·Granted Feb 27, 2024·0 cites·10 claims
- 1176US8252913B2Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeuticsSCHAUB ROBERT G·Filed 2010·Granted Aug 28, 2012·4 cites·36 claims
- 1275US8946184B2Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2013·Granted Feb 3, 2015·1 cites·20 claims
- 1362US2018030446A1Aptamer therapeutics useful in the treatment of complement-related disordersARCHEMIX LLC·Filed 2017·Application pending·0 cites
- 1457US2004180360A1Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the sameFiled 2003·Application pending·0 cites
- 1555US2024175028A1DOSING OF siRNA COMPOUNDS TO THE CISTERNA MAGNAALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1653US2007009476A1Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the sameWILSON CHARLES·Filed 2006·Application pending·0 cites
- 1753US2009269356A1Complement Binding Aptamers and Anti-C5 Agents Useful in the Treatment of Ocular DisordersEPSTEIN DAVID·Filed 2007·Application pending·0 cites
- 1850US8461318B2Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder thereapeuticsSCHAUB ROBERT·Filed 2011·Granted Jun 11, 2013·0 cites·1 claims
- 1950US2004253243A1Aptamer therapeutics useful in ocular pharmacotherapyFiled 2004·Application pending·0 cites
- 2045US2004018515A1Compositions selective for adenosine diphosphate and methods of using sameFiled 2003·Application pending·0 cites
- 2143US2017145416A1Complement Binding Aptamers and Anti-C5 Agents Useful in the Treatment of Ocular DisordersARCHEMIX LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey Kurz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →